Skip to Content

Liotrix Tablets

Last Updated: June 6, 2017
Status: Current

Liotrix Tablets

Products Affected - Description
  • Thyrolar oral tablet, Actavis (formerly Forest)
    12.5 mcg/3.1 mcg 100 count (NDC 00456-0040-01)

25 mcg/6.25 mcg 100 count (NDC 00456-0045-01)
150 mcg/37.5 mcg 100 count (NDC 00456-0060-01)
100 mcg/25 mcg 100 count (NDC 00456-0055-01)
50 mcg/12.5 mcg 100 count (NDC 00456-0050-01)
Reason for the Shortage
  • Thyrolar tablets from Actavis (formerly Forest) are on shortage due to manufacturing changes.

Available Products
  • No presentations are available.

Estimated Resupply Dates

  • Actavis (formerly Forest) has all Thyrolar presentations on long-term back order and the company cannot estimate a release date.

Updated

June 6, February 7, 2017; October 17, July 20, April 26, February 29, 2016; December 16, September 28, May 1, February 9, 2015; November 5, August 13, May 23, March 3, 2014; December 10, September 18, July 12, May 1, 2013; November 20, August 13, May 18, February 27, 2012; December 7, September 28, July 26, May 17, March 8, January 26, 2011; November 23, October 12, July 28, June 1, April 23, March 9, February 1, 2010; December 9, November 6, October 2, August 31, June 23 and 1, 2009; May 4, March 14, 2007; March 28, 2005, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide